Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation

Oncogene

Volumn 21, Issue 41, 2002, Pages 6317-6327

  Karimpour, Shervin ^a   Lou, Junyang ^b   Lin, Lilie L ^b   Rene, Luis M ^b   Lagunas, Lucio ^b   Ma, Xinrong ^c   Karra, Sreenivasu ^b,c   Bradbury, C Matthew ^a   Markovina, Stephanie ^b   Goswami, Prabhat C ^d   Spitz, Douglas R ^d   Hirota, Kiichi ^e   Kalvakolanu, Dhananjaya V ^c   Yodoi, Junji ^f   Gius, David ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e KYOTO UNIVERSITY HOSPITAL   (Japan)

^f KYOTO UNIVERSITY   (Japan)

Author keywords

AP 1; Ionizing radiation; Redox; Thioredoxin; Thioredoxin reductase

Indexed keywords

CYSTEINE; FLAVOPROTEIN; PROTEIN DERIVATIVE; REDOX EFFECTOR FACTOR 1; THIOREDOXIN; THIOREDOXIN REDUCTASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE DELETION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IONIZING RADIATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REPORTER GENE;

CYSTEINE; HELA CELLS; HUMANS; SIGNAL TRANSDUCTION; THIOREDOXIN; THIOREDOXIN REDUCTASE (NADPH); TRANSCRIPTION FACTOR AP-1;

MAMMALIA;

EID: 0037068769     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205749     Document Type: Article

References (39)

1. Abate C, Patel L, Rauscher III FJ and Curran T. (1990). Science, 249, 1157-1161.
2. Abate C, Marshak DR and Curran T. (1991). Oncogene, 6, 2179-2185.
3. Becker K, Gromer S, Schirmer RH and Müller S. (2000). Eur. J. Biochem., 267, 6118-6125.
4. Beetz A, Peter RU, Oppel T, Kaffenberger W, Rupec RA, Meyer M, van Beuningen D, Kind P and Messer G. (2000). Int. J. Radiat. Biol., 76, 1443-1453.
5. Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J and Powis G. (1996). Anticancer Res., 16, 3459-3466.
6. Curry HA, Clemens RA, Shah S, Bradbury CM, Botero A, Goswami P and Gius D. (1999). J. Biol. Chem., 274, 23061-23067.
7. Dignam JD. (1990). Meth. Enzymol., 182, 194-203.
8. Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaka PY, Berggren M, Briehl MM and Powis G. (1996). Cancer Res., 56, 5765-5770.
9. Franza Jr BR, Rauscher III FJ, Josephs SF and Curran T. (1988). Science, 239, 1150-1153.
10. Gius D, Cao XM, Rauscher III FJ, Cohen DR, Curran T and Sukhatme VP. (1990). Mol. Cell. Biol., 10, 4243-4255.
11. Hallahan DE, Gius D, Kuchibhotla J, Sukhatme V, Kufe DW and Weichselbaum RR. (1993). J. Biol. Chem., 268, 4903-4907.
12. Halliwell B and Gutteridge JM. (1988). Hum. Toxicol., 7, 7-13.
13. Halliwell B and Gutteridge JM. (1990). Methods Enzymol., 186, 1-85.
14. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K and Yodoi J. (1999). J. Biol. Chem, 274, 27891-27897.
15. Hirota K, Matsui M, Murata M, Takashima Y, Cheng FS, Itoh T, Fukuda K and Yodoi J. (2000a). Biochem. Biophys. Res. Comm., 274, 177-182.
16. Hirota K, Nakamura H, Arai T, Ishii H, Bai J, Itoh T, Fukuda K and Yodoi J. (2000b). Biochem. Biophys. Res. Comm., 275, 825-830.
17. Holbrook NJ and Fornace Jr AJ. (1991). New Biol., 3, 825-833.
18. Holmgren A and Bjornstedt M. (1995). Meth. Enzymol., 252, 199-208.
19. Hu J, Ma X, Lindner DJ, Karra S, Hofmann ER, Reddy SP and Kalvakolanu DV. (2001). Oncogene, 20, 4235-4248.
20. Karin M and Smeal T. (1992). Trends Biochem. Sci, 17, 418-422.
21. Kerppola T and Curran T. (1995). Nature, 373, 199-200.
22. Kerr LD, Inoue J and Verma IM. (1992). Curr. Opin. Cell Biol., 4, 496-501.
23. Kirkpatrick DL, Ehrmantraut G, Stettner S, Kunkel M and Powis G. (1997). Oncol. Res., 9, 351-356.
24. Maity A, McKenna WG and Muschel RJ. (1994). Radiother. Oncol., 31, 1-13.
25. Ma X, Karra S, Lindner DJ, Hu J, Reddy SP, Kimchi A, Yodoi J and Kalvakolanu DV. (2001). Oncogene, 20, 3703-3715.
26. Martin M, Vozenin MC, Gault N, Crechet F, Pfarr CM and Lefaix JL. (1997). Oncogene, 18, 981-989.
27. Mustacich D and Powis G. (2000). Biochem. J., 346, 1-8.
28. Oberley TD, Verwiebe E, Zhong W, Kang SW and Rhee SG. (2001). Free Radic. Biol. Med., 30, 412-424.
29. Poole LB, Reynolds CM, Wood ZA, Karplus PA, Ellis HR and Calzi ML. (2000). Eur. J. Biochem., 267, 6126-6133.
30. Powis G, Kirkpatrick DL, Angulo M and Baker A. (1998). Chem. Biol. Interact., 112, 23-34.
31. Sasada T, Sono H and Yodoi J. (1996). J. Toxicol. Sci., 21, 285-287.
32. Spitz DR, Sim JE, Ridnour LA, Galoforo SS and Lee YJ. (2000). Ann. NY Acad. Sci., 899, 349-362.
33. Storz G, Tartaglia LA and Ames BN. (1990). Science, 248, 189-194.
34. Tuttle SW, Varnes ME, Mitchell JB and Biaglow JE. (1992). Int. J. Radiat. Onc. Biol. Phys., 22, 671-675.
35. Wei SJ, Botero A, Hirota K, Bradbury CM, Markovina S, Laszlo A, Spitz DR, Goswami PC, Yodoi J and Gius D, (2000). Cancer Res., 60, 6688-6695.
36. Williams CH, Arscott DL, Müller S, Lennon BW, Ludwig ML, Wang PM, Veine DM, Becker K and Heiner Schirmer R. (2000). Eur. J. Biochem., 267, 6110-6119.
37. Xanthoudakis S and Curran T. (1992). EMBO J., 11, 653-664
38. Xanthoudakis S, Miao G, Wang F, Pan Y-C and Curran T. (1992). EMBO J., 11, 3323-3335.
39. Xanthoudakis S and Curran T. (1996). Adv. Exp Med. Biol., 387, 69-75.